Concepedia

Xuling Su

XS

Statistics

Publications

3

Citations

65

H-Index

3

Active since

2019

Affiliations

First Hospital of Jilin University(Current)

Jilin University

Xuling Su is an author at First Hospital of Jilin University specializing in molecular biology, life sciences, and nrf2 pathway activation.

Publications per year

2019–2025

3

Publications

3

Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification

Xuling Su, Shudong Wang, Haiying Zhang et al. · Journal of Cellular and Molecular Medicine · 2021 · 32 citations · Full text

, , +15

<p>YAP/TAZ: a promising target for squamous cell carcinoma treatment</p>

Xiaoming Dong, Lingbin Meng, Pinyi Liu et al. · Cancer Management and Research · 2019 · 20 citations · Full text

, , +15

Bisphenol A exposure enhances proliferation and tumorigenesis of papillary thyroid carcinoma through ROS generation and activation of NOX4 signaling pathways

Yi Wang, Xuling Su, Qianqian Wang et al. · Ecotoxicology and Environmental Safety · 2025 · 13 citations · Full text

, , +16

1–3 of 3